Cancer Registry Software Market Size, Share, & Trends Analysis Report By Software (Standalone), By Deployment Model (On-Premise), By Component (Commercial), By End Use (Government & Third Party), By Region, And Segment Forecasts, 2019 - 2026

Published: Sep, 2019 | Pages: 100 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global cancer registry software market size is expected to reach USD 103.5 million by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.5%. Growing incidence of cancer is expected to aid growth over the forecast period. Currently, cancer is the second leading cause of death globally, and according to WHO, around 70% of the deaths occur in low- and middle-income countries.

Moreover, rising adoption of Electronic Health Records (EHRs) in developed countries and increasing need for cancer registries for post-marketing surveillance are among the factors further anticipated to boost the demand for cancer registry software in the coming years. Market players are constantly involved in software updation in an attempt to minimize security risks and provide efficient software, thereby increasing market visibility and adoption. For instance, in April 2018, Elekta invested in PalabraApps LLC to improve its MOSAIQ Oncology Information System software.

Increasing number of clinical trials being conducted by major pharmaceutical and biotechnological companies is expected to drive the market over the forecast period. Cancer registry data helps in tracking patients for clinical trials. Moreover, the affected locations for any specific type of cancer can be identified by using this software. Major pharmaceutical companies are increasingly preferring cancer registry software owing to less requirement of internal staff, increased cost-effectiveness, and efficient management of resources, which is further widening the scope for growth.

Further key findings from the report suggest:

• Increasing cancer burden in developing and developed countries is expected to create growth opportunities in the cancer registry software market

• Standalone segment accounted for the largest revenue share in 2018, as it allows multiple system usage and provides other advantages such as automatic upgrade and easy-to-use tools

• On basis of deployment model, on-premise segment held the largest share due to high data security and low risk of data breach

• On the basis of component, commercial database held the largest revenue share due to better compliance features than public database

• Government & third-party organizations accounted for the largest revenue owing to increasing adoption of this software by government agencies for east data tracking

• North America held the largest revenue share as of 2018 due to supportive government initiatives and presence of key industry players

• Asia Pacific is anticipated to witness lucrative growth due to increasing government initiatives and presence of untapped opportunities

• Some of the market key players are Elekta, C/NET Solutions, Electronic Registry Systems, Inc., Onco, Inc., McKesson Corporation, and Rocky Mountain.

 Table of Contents

Chapter 1 Research Methodology & Scope
                 1.1 Market Segmentation & Scope
                     1.1.1 Estimates and forecast timeline
                 1.2 Research Methodology
                 1.3 Information Procurement
                     1.3.1 Purchased database:
                     1.3.2 GVR's internal database
                     1.3.3 Secondary sources
                     1.3.4 Primary research:
                     1.3.5 Details of Primary Research
                         1.3.5.1 Data for primary interviews in North America
                         1.3.5.2 Data for primary interviews in Europe
                         1.3.5.3 Data for primary interviews in Asia Pacific
                         1.3.5.4 Data for primary interviews in Middle East and Africa
                 1.4 Information or Data Analysis
                     1.4.1 Data analysis models
                 1.5 Market Formulation & Validation
                 1.6 Model Details
                     1.6.1 Commodity flow analysis (Model 1)
                         1.6.1.1 Approach 1: Commodity flow approach
                 1.7 List of Secondary Sources
                 1.8 List of Primary Sources
                 1.9 Report Objectives
Chapter 2 Executive Summary
                 2.1 Market Outlook
                     2.1.1 Cancer registry software market outlook, 2014 - 2026 (USD Million)
                 2.2 Segment Outlook
                 2.3 Competitive Outlook
                 2.4 Cancer Registry Software Market Summary, 2018
Chapter 3 Cancer Registry Software Market Variables, Trends, & Scope
                 3.1 Market Lineage Outlook
                     3.1.1 Parent market analysis
                     3.1.2 Ancillary market analysis
                 3.2 Penetration & Growth Prospect Mapping
                 3.3 Technology Timeline Overview
                     3.3.1 Technology timeline cancer registry software changing technology & adoption
                 3.4 Cancer Registry Software Market Dynamics
                     3.4.1 Market driver analysis
                         3.4.1.1 Increasing prevalence of cancer
                         3.4.1.2 Rising pressure to improve the quality of care and reduce healthcare costs
                         3.4.1.3 Growing use of cancer patient registry data for post-marketing surveillance
                     3.4.2 Market restraint analysis
                         3.4.2.1 Data privacy and security concerns
                 3.5 Cancer Registry Software Market Analysis Tools: Porters
                     3.5.1 Supplier power
                     3.5.2 Buyer power
                     3.5.3 Threat of substitutes
                     3.5.4 Threat of new entrants
                     3.6.5 Competitive rivalry
                 3.6 PESTEL Analysis
                     3.6.1 Political landscape
                     3.6.2 Economic landscape
                     3.6.3 Technology landscape
                     3.6.4 Social landscape
                 3.7 Major Deals & Strategic Alliances Analysis
                     3.7.1 Mergers & acquisitions
                     3.7.2 Product launch
                     3.7.3 Expansion
                     3.7.4 Partnership & collaborations
Chapter 4 Cancer Registry Software Market: Competitive Analysis
                 4.1 Market Participation Categorization
                 4.2 Public Companies
                     4.2.1 Company market position analysis
                     4.2.2 Competitive Dashboard Analysis
                         4.2.2.1 Market differentiators
                     4.2.3 Company market share
                     4.2.4 Competitive dashboard analysis
                 4.3 Private Companies
                     4.3.1 List of key emerging companies
Chapter 5 Cancer Registry Software Market: Software Estimates & Trend Analysis
                 5.1 Software Market Share Analysis, 2018 & 2026
                 5.2 Software Dashboard
                     5.2.1 Standalone
                         5.2.1.1 Standalone market estimates and forecasts, 2014 - 2026 (USD Million)
                     5.2.2 Integrated
                         5.2.2.1 integrated market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 6 Cancer Registry Software Market: Deployment Model Estimates & Trend Analysis
                 6.1 Deployment Model Market Share Analysis, 2018 & 2026
                 6.2 Deployment Model Dashboard
                 6.3 On-premise
                     6.3.1 On-premise market estimates and forecasts, 2014 - 2026 (USD Million)
                 6.4 Cloud Based
                     6.4.1 Cloud-based drugs market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 7 Cancer Registry Software Market: Component Estimates & Trend Analysis
                 7.1 Component Market Share Analysis, 2018 & 2026
                 7.2 Component Dashboard
                 7.3 Commercial
                     7.3.1 Commercial market estimates and forecasts, 2014 - 2026 (USD Million)
                 7.4 Public
                     7.4.1 Public market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 8 Cancer Registry Software Market: End-use Estimates & Trend Analysis
                 8.1 End-use Market Share Analysis, 2018 & 2026
                 8.2 End-Use Dashboard
                 8.3 Government& Third Party
                     8.3.1 Government & third party market estimates and forecasts, 2014 - 2026 (USD Million)
                 8.4 Private payers
                     8.4.1 Private payers market estimates and forecasts, 2014 - 2026 (USD Million)
                 8.5 Hospital and Medicine practice
                     8.5.1 Hospital & Medicine practice market estimates and forecasts, 2014 - 2026 (USD Million)
                 8.6 Pharma Biotech & Medical Device Companies
                     8.6.1 Pharma biotech and medical device companies market estimates and forecasts, 2014 - 2026 (USD Million)
                 8.7 Research Institutes
                     8.7.1 Research institutes market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 9 Cancer Registry Software Market: Regional Estimates & Trend Analysis, by Software, Deployment Model, Component, and End Use
                 9.1 Regional Market Snapshot
                 9.2 Market Share Analysis by Country, 2018
                     9.2.1 North America
                     9.2.2 Europe
                     9.2.3 Asia Pacific
                     9.2.4 Latin America
                     9.2.5 MEA
                 9.3 North America
                     9.3.1 North America cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.3.2 U.S.
                         9.3.2.1 U.S. cancer registry software market estimates and forecasts, 2014 - 2026(USD Million)
                     9.3.3 Canada
                         9.3.3.1 Canada cancer registry software market estimates and forecasts, 2014 - 2026(USD Million)
                 9.4 Europe
                     9.4.1 Europe cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.4.2 U.K.
                         9.4.2.1 U.K. cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.4.3 Germany
                         9.4.3.1 Germany cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.4.4 France
                         9.4.4.1 France cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.4.5 Italy
                         9.4.5.1 Italy cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.4.6 Spain
                         9.4.6.1 Spain cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.4.7 Russia
                         9.4.7.1 Russia cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                 9.5 Asia Pacific
                     9.5.1 Asia Pacific cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.5.2 Japan
                         9.5.2.1 Japan cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.5.3 China
                         9.5.3.1 China cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.5.4 India
                         9.5.4.1 India cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                 9.6 Latin America
                     9.6.1 Latin America cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.6.2 Mexico
                         9.6.2.1 Mexico cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.6.3 Brazil
                         9.6.3.1 Brazil cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                 9.7 MEA
                     9.7.1 MEA cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.7.2 South Africa
                         9.7.2.1 South Africa cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.7.3 Saudi Arabia
                         9.7.3.1 Saudi Arabia cancer registry software market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 10 Company Profiles
                 10.1 Onco, Inc.
                     10.1.1 Company overview
                     10.1.2 Financial performance
                     10.1.3 Product benchmarking
                     10.1.4 Strategic initiatives
                 10.2 C/net Solutions
                     10.2.1 Company overview
                     10.2.2 Product benchmarking
                     10.2.3 Strategic initiatives
                 10.3 Elekta AB
                     10.3.1 Company overview
                     10.3.2 Financial performance
                     10.3.3 Product benchmarking
                     10.3.4 Strategic initiatives
                 10.4 Rocky Mountain Cancer Data System
                     10.4.1 Company overview
                     10.4.2 Financial performance
                     10.4.3 Product benchmarking
                     10.4.4 Strategic initiatives
                 10.5 Electronic Registry System, Inc.
                     10.5.1 Company overview
                     10.5.2 Product benchmarking
                     10.5.3 Strategic initiatives
                 10.6 McKesson Corporation
                     10.6.1 Company overview
                     10.6.2 Financial performance
                     10.6.3 Product benchmarking
                     10.6.4 Strategic initiatives
                 10.7 Ordinal data, Inc.
                     10.7.1 Company overview
                     10.7.2 Product benchmarking
                 10.8 Conduent, Inc.
                     10.8.1 Company overview
                     10.8.2 Financial performance
                     10.8.3 Product benchmarking
                     10.8.4 Strategic initiatives
                 10.9 IBM
                     10.9.1 Company overview
                     10.9.2 Financial performance
                     10.9.3 Product benchmarking
                     10.9.4 Strategic initiatives
                 10.10 Himagine, Inc.
                     10.10.1 Company overview
                     10.10.2 Financial performance
                     10.10.3 Product benchmarking
                     10.10.4 Strategic initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of key emerging companies
TABLE 3 North America cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 4 North America cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 5 North America cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 6 North America cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 7 U.S. cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 8 U.S. cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 9 U.S. cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 10 U.S. cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 11 Canada cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 12 Canada cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 13 Canada cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 14 Canada cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 15 Europe cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 16 Europe cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 17 Europe cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 18 Europe cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 19 U.K. cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 20 U.K. cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 21 U.K. cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 22 U.K. cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 23 Germany cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 24 Germany cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 25 Germany cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 26 France cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 27 France cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 28 France cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 29 France cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 30 Italy cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 31 Italy cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 32 Italy cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 33 Italy cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 34 Spain cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 35 Spain cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 36 Spain cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 37 Spain cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 38 Russia cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 39 Russia cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 40 Russia cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 41 Russia cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 42 Asia Pacific cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 43 Asia Pacific cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 44 Asia Pacific cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 45 Asia Pacific cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 46 Japan cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 47 Japan cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 48 Japan cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 49 Japan cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 50 China cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 51 China cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 52 China cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 53 China cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 54 India cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 55 India cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 56 India cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 57 India cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 58 Latin America cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 59 Latin America cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 60 Latin America cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 61 Latin America cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 62 Brazil cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 63 Brazil cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 64 Brazil cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 65 Brazil cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 66 Mexico cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 67 Mexico cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 68 Mexico cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 69 Mexico cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 70 MEA cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 71 MEA cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 72 MEA cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 73 MEA cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 74 South Africa cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 75 South Africa cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 76 South Africa cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 77 South Africa cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)
TABLE 78 Saudi Arabia cancer registry software market estimates and forecasts, by software, 2014 - 2026 (USD Million)
TABLE 79 Saudi Arabia cancer registry software market estimates and forecasts, by deployment model, 2014 - 2026 (USD Million)
TABLE 80 Saudi Arabia cancer registry software market estimates and forecasts, by Component, 2014 - 2026 (USD Million)
TABLE 81 Saudi Arabia cancer registry software market estimates and forecasts, by end use, 2014 - 2026 (USD Million)

List of Figures

FIG. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Primary interviews in North America
FIG. 6 Primary interviews in Europe
FIG. 7 Primary interviews in Asia Pacific
FIG. 8 Primary interviews in Middle East and Africa
FIG. 9 Market research approaches
FIG. 10 Value-chain-based sizing & forecasting
FIG. 11 QFD modeling for market share assessment
FIG. 12 Market formulation & validation
FIG. 13 Commodity flow analysis
FIG. 14 Cancer registry software market snapshot
FIG. 15 Penetration & growth prospect mapping
FIG. 16 Technology impact analysis
FIG. 17 Cancer registry software market dynamics
FIG. 18 Cancer registry software market driver impact
FIG. 19 Cancer registry software market restraint impact
FIG. 20 Strategy mapping
FIG. 21 Market participant categorization
FIG. 22 Company market position analysis
FIG. 23 Market differentiators
FIG. 24 Company market share analysis
FIG. 25 Competitive dashboard analysis
FIG. 26 Cancer registry software market: Software movement analysis
FIG. 27 Cancer registry software market software dashboard
FIG. 28 Global standalone market, 2014 - 2026 (USD Million)
FIG. 29 Global integrated market, 2014 - 2026 (USD Million)
FIG. 30 Cancer registry software market: Deployment model movement analysis
FIG. 31 Cancer registry software deployment model dashboard
FIG. 32 Global on-premise market, 2014 - 2026 (USD Million)
FIG. 33 Global cloud-based drugs market, 2014 - 2026 (USD Million)
FIG. 34 Cancer registry software market: Component movement analysis
FIG. 35 Cancer registry software Component dashboard
FIG. 36 Global commercial market, 2014 - 2026 (USD Million)
FIG. 37 Global public market, 2014 - 2026 (USD Million)
FIG. 38 Cancer registry software market: End-use movement analysis
FIG. 39 Cancer registry software end-use dashboard
FIG. 40 Global government & third party market, 2014 - 2026 (USD Million)
FIG. 41 Global private payers market, 2014 - 2026 (USD Million)
FIG. 42 Global hospital & medicine practice market, 2014 - 2026 (USD Million)
FIG. 43 Global pharma biotech & medical device companies market, 2014 - 2026 (USD Million)
FIG. 44 Global research institutes market, 2014 - 2026 (USD Million)
FIG. 45 Regional marketplace: Key takeaways
FIG. 46 North America cancer registry software market share by countries, 2018
FIG. 47 Europe cancer registry software market share by countries, 2018
FIG. 48 Asia Pacific cancer registry software market share by countries, 2018
FIG. 49 Latin America cancer registry software market share by countries, 2018
FIG. 50 MEA cancer registry software market share by countries, 2018
FIG. 51 Regional outlook, 2018 & 2026
FIG. 52 North America cancer registry software market, 2014 - 2026 (USD Million)
FIG. 53 U.S. cancer registry software market, 2014 - 2026 (USD Million)
FIG. 54 Canada cancer registry software market, 2014 - 2026 (USD Million)
FIG. 55 Europe cancer registry software market, 2014 - 2026 (USD Million)
FIG. 56 U.K. cancer registry software market, 2014 - 2026 (USD Million)
FIG. 57 Germany cancer registry software market, 2014 - 2026 (USD Million)
FIG. 58 France cancer registry software market, 2014 - 2026 (USD Million)
FIG. 59 Italy cancer registry software market, 2014 - 2026 (USD Million)
FIG. 60 Spain cancer registry software market, 2014 - 2026 (USD Million)
FIG. 61 Russia cancer registry software market, 2014 - 2026 (USD Million)
FIG. 62 Asia Pacific cancer registry software market, 2014 - 2026 (USD Million)
FIG. 63 Japan cancer registry software market, 2014 - 2026 (USD Million)
FIG. 64 China cancer registry software market, 2014 - 2026 (USD Million)
FIG. 65 India cancer registry software market, 2014 - 2026 (USD Million)
FIG. 66 Latin America cancer registry software market, 2014 - 2026 (USD Million)
FIG. 67 Mexico cancer registry software market, 2014 - 2026 (USD Million)
FIG. 68 Brazil cancer registry software market, 2014 - 2026 (USD Million)
FIG. 69 MEA cancer registry software market, 2014 - 2026 (USD Million)
FIG. 70 South Africa cancer registry software market, 2014 - 2026 (USD Million)
FIG. 71 Saudi Arabia cancer registry software market, 2014 - 2026 (USD Million)